Table 1.
Sample demographic variables.
| Schizophrenia | Controls | t/χ2 | df | p-Values | |
|---|---|---|---|---|---|
| No. of subjects | 43a | 34 | |||
| Gender (% female) | 62.8 | 37.2 | 1.3 | 1 | 0.354 |
| Age (years) | 34.1 ± 10.9 | 37.1 ± 12.3 | − 1.2 | 75 | 0.231 |
| Education (years) | 12.9 ± 4.0 | 16.2 ± 4.1 | − 3.4 | 75 | 0.001 |
| PANSS total score | 57.4 ± 17.3 | – | – | – | – |
| PANSS positive syndrome score | 15.4 ± 5.7 | – | – | – | – |
| PANSS negative syndrome score | 14.6 ± 6.4 | – | – | – | – |
| Chlorpromazine equivalents (mg) | 457.4 ± 333.7 | – | – | – | – |
| Mean duration of illness (years) | 8.7 ± 9.3 | – | – | – | – |
| Number of psychotic episodes | 4.1 ± 5.1 | – | – | – | – |
| Gray matter volume (ml) | 705.9 ± 113.1 | 756.9 ± 80.2 | − 2.2 | 75 | 0.029 |
a
Patient subgroups: sED: n = 14; mED: n = 22; nED: n = 7; − sED: n = 6; + sED: n = 8. Severe emotional dysregulation (sED), mild emotional dysregulation (mED), and no emotional dysregulation (nED).